Manulife (Manufacturers Life Insurance)’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.9M Sell
184,117
-10,407
-5% -$447K 0.01% 971
2025
Q4
$8.53M Sell
194,524
-5,210
-3% -$216K 0.01% 953
2025
Q3
$8.25M Sell
199,734
-9,633
-5% -$387K 0.01% 955
2025
Q2
$9.23M Sell
209,367
-22,013
-10% -$880K 0.01% 877
2025
Q1
$8.54M Sell
231,380
-5,971
-3% -$213K 0.01% 911
2024
Q4
$7.9M Sell
237,351
-3,686
-2% -$120K 0.01% 1001
2024
Q3
$6.25M Sell
241,037
-12,805
-5% -$318K 0.01% 1117
2024
Q2
$5.7M Sell
253,842
-88,534
-26% -$1.96M 0.01% 1108
2024
Q1
$8.12M Sell
342,376
-298
-0.1% -$6.62K 0.01% 959
2023
Q4
$8.22M Sell
342,674
-34,625
-9% -$753K ﹤0.01% 931
2023
Q3
$8.24M Sell
377,299
-8,526
-2% -$178K ﹤0.01% 896
2023
Q2
$7.37M Sell
385,825
-3,587
-0.9% -$69.1K ﹤0.01% 904
2023
Q1
$7.56M Sell
389,412
-9,763
-2% -$170K ﹤0.01% 910
2022
Q4
$6.35M Sell
399,175
-8,875
-2% -$145K ﹤0.01% 962
2022
Q3
$6.42M Sell
408,050
-24,591
-6% -$475K ﹤0.01% 941
2022
Q2
$9M Sell
432,641
-20,642
-5% -$425K 0.01% 855
2022
Q1
$10.2M Buy
453,283
+96,057
+27% +$1.88M 0.01% 893
2021
Q4
$6.58K Sell
357,226
-5,525
-2% -$106K ﹤0.01% 1134
2021
Q3
$7.67M Buy
362,751
+19,619
+6% +$364K 0.01% 1062
2021
Q2
$6.25M Sell
343,132
-6,899
-2% -$161K 0.01% 1173
2021
Q1
$7.91M Sell
350,031
-23,403
-6% -$529K 0.01% 1063
2020
Q4
$7.5M Sell
373,434
-31,537
-8% -$660K 0.01% 1030
2020
Q3
$9.9M Sell
404,971
-6,103
-1% -$142K 0.01% 804
2020
Q2
$9.34M Sell
411,074
-24,146
-6% -$560K 0.01% 807
2020
Q1
$7.49M Buy
435,220
+8,787
+2% +$161K 0.01% 839
2019
Q4
$7.51M Sell
426,433
-23,135
-5% -$392K 0.01% 1005
2019
Q3
$8.09M Sell
449,568
-42,261
-9% -$855K 0.01% 939
2019
Q2
$10.5M Buy
491,829
+2,151
+0.4% +$45.1K 0.01% 814
2019
Q1
$11.7M Sell
489,678
-13,706
-3% -$313K 0.01% 779
2018
Q4
$9.9M Buy
503,384
+9,568
+2% +$171K 0.01% 796
2018
Q3
$8.75M Buy
493,816
+55,643
+13% +$1.09M 0.01% 954
2018
Q2
$9.43M Buy
438,173
+429,718
+5,082% +$8.89M 0.01% 917
2018
Q1
$187K Sell
8,455
-365
-4% -$10.1K ﹤0.01% 3070
2017
Q4
$268K Sell
8,820
-189
-2% -$5.03K ﹤0.01% 2794
2017
Q3
$218K Buy
9,009
+5
+0.1% +$133 ﹤0.01% 2913
2017
Q2
$222K Sell
9,004
-168,037
-95% -$3.56M ﹤0.01% 2921
2017
Q1
$3.84M Buy
177,041
+22,547
+15% +$459K ﹤0.01% 1244
2016
Q4
$2.3M Sell
154,494
-225
-0.1% -$3.25K ﹤0.01% 1347
2016
Q3
$1.98M Buy
154,719
+54
+0% +$584 ﹤0.01% 1379
2016
Q2
$1.21M Buy
154,665
+3,727
+2% +$21.5K ﹤0.01% 1514
2016
Q1
$588K Buy
150,938
+4,766
+3% +$20.2K ﹤0.01% 1901
2015
Q4
$824 Buy
146,172
+1,447
+1% +$8.1K ﹤0.01% 1727
2015
Q3
$812 Buy
144,725
+19,054
+15% +$104K ﹤0.01% 1713
2015
Q2
$473 Sell
125,671
-6,452
-5% -$21K ﹤0.01% 2157
2015
Q1
$340 Sell
132,123
-1,500
-1% -$3.48K ﹤0.01% 2346
2014
Q4
$192 Buy
133,623
+5,987
+5% +$9.33K ﹤0.01% 2677
2014
Q3
$195 Buy
127,636
+2,777
+2% +$8.91K ﹤0.01% 2650
2014
Q2
$423K Sell
124,859
-21,132
-14% -$73K ﹤0.01% 2158
2014
Q1
$516 Buy
145,991
+5,290
+4% +$36K ﹤0.01% 2058
2013
Q4
$863 Sell
140,701
-388
-0.3% -$2.14K ﹤0.01% 1690
2013
Q3
$822 Sell
141,089
-3,923
-3% -$20.3K ﹤0.01% 1667
2013
Q2
$658K Buy
+145,012
New +$687K ﹤0.01% 1715

Other funds holding EXEL

Manulife (Manufacturers Life Insurance)'s EXEL Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Exelixis (EXEL) stake by 5.3% in Q1 2026, selling an estimated $447K and leaving 184,117 shares worth $7.9M. The position accounts for 0.01% of the portfolio, ranked #971.

Manulife (Manufacturers Life Insurance) first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.7M in Q1 2019. 696 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 184,117 shares of Exelixis worth $7.9M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 10,407 Exelixis shares in Q1 2026, an estimated $447K.
  • Exelixis made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #971 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Exelixis position peaked at $11.7M in Q1 2019.
  • 696 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.